Financial PerformanceSIBN delivered strong top-line results with year-over-year growth in active surgeons and double-digit procedure growth, reflecting a robust financial performance.
Product LaunchThe full launch of Granite 9.5 is anticipated to boost SIBN's growth in the latter half of the year, showcasing the company's innovative capabilities.
Strategic GrowthSIBN's strategic focus on training interventionalists is expanding patient access and is poised to foster growth within the medical technology industry.